All very confidential in the annual report about the HPV program
Partnering before a clinical study in humans will send this well north
Only a matter of time
- Forums
- ASX - By Stock
- HPV trial
All very confidential in the annual report about the HPV program...
-
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$9.41 |
Change
-0.500(5.05%) |
Mkt cap ! $202.9M |
Open | High | Low | Value | Volume |
$9.50 | $9.61 | $9.31 | $93.50K | 9.844K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 956 | $9.41 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.67 | 923 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 47 | 9.500 |
1 | 943 | 9.410 |
1 | 99 | 9.310 |
1 | 2000 | 9.300 |
2 | 412 | 9.200 |
Price($) | Vol. | No. |
---|---|---|
9.670 | 923 | 6 |
9.680 | 161 | 1 |
9.690 | 180 | 1 |
9.700 | 180 | 1 |
9.910 | 13 | 1 |
Last trade - 12.15pm 13/11/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online